Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100RJUD
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥737m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥891m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥891m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥36.1bnat 2023-06-30Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥28.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥23.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.5bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥73.662023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio35.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥86m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥70m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥15m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥212m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥328m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2023-04-01 → 2023-06-30¥875m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥269m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2023-04-01 → 2023-06-30¥190m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥137m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-06-30¥36m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-06-30¥453m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-06-30¥277m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥176m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-06-30−¥49m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.3bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥174m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-06-30¥5.3bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥4.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥758m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥774m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥370m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥359m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥40m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥483m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥256m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥38m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 402
ItemContextValueUnit
Investments and other assetsPrior1YearInstant5837000000JPY
Investments and other assetsCurrentQuarterInstant6312000000JPY
Noncurrent assetsPrior1YearInstant19800000000JPY
Noncurrent assetsCurrentQuarterInstant21347000000JPY
AssetsPrior1YearInstant35129000000JPY
AssetsCurrentQuarterInstant36075000000JPY
Accounts payable tradePrior1YearInstant576000000JPY
Accounts payable tradeCurrentQuarterInstant415000000JPY
Short term loans payablePrior1YearInstant6360000000JPY
Short term loans payableCurrentQuarterInstant6860000000JPY
Current portion of long term loans payablePrior1YearInstant2172000000JPY
Current portion of long term loans payableCurrentQuarterInstant2189000000JPY
Income taxes payablePrior1YearInstant395000000JPY
Income taxes payableCurrentQuarterInstant224000000JPY
Contract liabilitiesPrior1YearInstant372000000JPY
Contract liabilitiesCurrentQuarterInstant361000000JPY
Lease obligations clPrior1YearInstant148000000JPY
Lease obligations clCurrentQuarterInstant164000000JPY
Provision for bonusesPrior1YearInstant－JPY
Provision for bonusesCurrentQuarterInstant80000000JPY
Other clPrior1YearInstant2361000000JPY
Other clCurrentQuarterInstant2330000000JPY
Current liabilitiesPrior1YearInstant12385000000JPY
Current liabilitiesCurrentQuarterInstant12626000000JPY
Long term loans payablePrior1YearInstant8646000000JPY
Long term loans payableCurrentQuarterInstant8576000000JPY
Deferred tax liabilitiesPrior1YearInstant3000000JPY
Deferred tax liabilitiesCurrentQuarterInstant59000000JPY
Asset retirement obligations nclPrior1YearInstant150000000JPY
Asset retirement obligations nclCurrentQuarterInstant161000000JPY
Guarantee deposits received2 nclPrior1YearInstant390000000JPY
Guarantee deposits received2 nclCurrentQuarterInstant390000000JPY
Net defined benefit liabilityPrior1YearInstant170000000JPY
Net defined benefit liabilityCurrentQuarterInstant169000000JPY
Lease obligations nclPrior1YearInstant1183000000JPY
Lease obligations nclCurrentQuarterInstant1210000000JPY
Other nclPrior1YearInstant44000000JPY
Other nclCurrentQuarterInstant124000000JPY
Noncurrent liabilitiesPrior1YearInstant10589000000JPY
Noncurrent liabilitiesCurrentQuarterInstant10693000000JPY
LiabilitiesPrior1YearInstant22974000000JPY
LiabilitiesCurrentQuarterInstant23319000000JPY
Capital stockPrior1YearInstant3899000000JPY
Capital stockCurrentQuarterInstant3899000000JPY
Capital surplusPrior1YearInstant1495000000JPY
Capital surplusCurrentQuarterInstant1495000000JPY
Retained earningsPrior1YearInstant7036000000JPY
Retained earningsCurrentQuarterInstant7565000000JPY
Treasury stockPrior1YearInstant-424000000JPY
Treasury stockCurrentQuarterInstant-424000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass